Treatment and clinical outcomes of patients relapsing after allogeneic hematopoietic cell transplantation for myelodysplastic syndrome

BACKGROUND: Although allogeneic hematopoietic cell transplantation (HCT) is the only curative treatment option for myelodysplastic syndrome (MDS), a substantial number of patients experience relapse. We reviewed the clinical outcomes of patients with MDS who relapsed after allogeneic HCT. METHODS: T...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Res
Main Authors: Choi, Eun-Ji, Lee, Je-Hwan, Lee, Jung-Hee, Park, Han-Seung, Ko, Sun-Hye, Seol, Miee, Lee, Young-Shin, Kang, Young-Ah, Jeon, Mijin, Lee, Kyoo-Hyung
Formato: Artigo
Idioma:Inglês
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300680/
https://ncbi.nlm.nih.gov/pubmed/30588465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2018.53.4.288
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares